- NSE
- INDRAMEDCO
- BSE
- 532150
- ISIN
- INE681B01017
INDRAPRASTHA MEDICAL CORP
Healthcare· Healthcare Services· Hospital
₹331.50
+₹1.30 (+0.39%)
NSE close ·
INDRAPRASTHA MEDICAL CORP closed at ₹331.50 on 9 Nov 2026, up 0.39% on the day, and is down 46.52% over the past year.
Price history
Between 10 Nov 2025 and 9 Nov 2026, the closing price ranged from ₹299.80 to ₹555.00.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹3,039 Cr
- Industry P/E
- 57.1
- Dividend yield
- 1.21%
Market cap and yield at the 9 Nov 2026 close. Industry P/E is the median of 6 Healthcare Services stocks.
Quarterly results
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Jun 2026 | ₹415 Cr | ₹55.85 Cr | — | ₹6.09 |
Armor risk check
INDRAPRASTHA MEDICAL CORP moves about 2× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is INDRAPRASTHA MEDICAL CORP's share price today?
INDRAPRASTHA MEDICAL CORP (NSE: INDRAMEDCO) closed at ₹331.50 on 9 Nov 2026, up 0.39% from the previous close of ₹330.20. It traded between ₹329.00 and ₹339.90 that day.
What are INDRAPRASTHA MEDICAL CORP's 52-week high and low?
Over the last 52 weeks INDRAPRASTHA MEDICAL CORP traded between ₹293.65 and ₹623.00, adjusted for splits and bonuses.
What are INDRAPRASTHA MEDICAL CORP's NSE symbol, BSE code and ISIN?
INDRAPRASTHA MEDICAL CORP has NSE symbol INDRAMEDCO, BSE code 532150, ISIN INE681B01017.
How has INDRAPRASTHA MEDICAL CORP performed over 1, 3 and 5 years?
INDRAPRASTHA MEDICAL CORP's share price return: 1Y −46.52%, 3Y +19.91% a year, 5Y +34.05% a year. Dividends are not included.
Does INDRAPRASTHA MEDICAL CORP pay a dividend?
Yes. INDRAPRASTHA MEDICAL CORP's latest dividend went ex on 18 Sep 2026: Final · ₹4.00 per share. Dividends over the past year come to a yield of 1.21% at the latest close.
What is INDRAPRASTHA MEDICAL CORP's market cap?
INDRAPRASTHA MEDICAL CORP's market cap is ₹3,039 Cr at the close on 9 Nov 2026.
Which sector is INDRAPRASTHA MEDICAL CORP in?
INDRAPRASTHA MEDICAL CORP is in NSE's Healthcare sector, in the Healthcare Services industry (Hospital).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how INDRAPRASTHA MEDICAL CORP fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app